Condition: Diabetes Type 2 · Sponsor: Scripps Whittier Diabetes Institute
The current research study will add continuous glucose monitoring devices to the evidence-based text messaging diabetes education program for patients with type 2 diabetes for 6 months. Results on the effectiveness of this intervention will be compared for non-insulin using patients.
This description comes directly from the study's public registry record.
Kallie Brown, PhD · 858-258-3555 · brown.kallie@scrippshealth.org
Athena Philis-Tsimikas, MD · 877-944-8843 · philis-Tsimikas.athena@scrippshealth.org
Always discuss trial participation with your own doctor first.
| Scripps Whittier Diabetes Institute | San Diego, California, United States | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06296550